Does reperfusion injury still cause significant mortality after lung transplantation?
about
Revisiting successful transplantation with marginal lungs: Fourteen years later, a new era of extended criteria.Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor AntagonismInfluence of hemodialysis on clinical outcomes after lung transplantationReceptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation modelNatural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury.Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury.Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets.Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model.Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat.Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia-reperfusion injury in rats.The functional study of human umbilical cord mesenchymal stem cells harbouring angiotensin-converting enzyme 2 in rat acute lung ischemia-reperfusion injury model.Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.Shock Wave Therapy Enhances Mitochondrial Delivery into Target Cells and Protects against Acute Respiratory Distress Syndrome
P2860
Q30275908-3D9FEE51-8ACF-474B-99B4-09BA6F77AF21Q30276921-F16B4D98-04A6-41C9-A985-0A9F7AC3CC61Q30409691-5167726F-EED1-4545-A52A-4DA0DF9926BDQ30410928-99AD5E5C-A20F-4D4B-AEDD-71FCCC945BA3Q30422075-C98667D9-E34C-487F-BB27-5F1AE959AED7Q30424759-A6656451-3392-4B8D-AABA-D9BAD08D2287Q30426574-E9C7AE7A-5E91-41C7-8288-43D09DF5448EQ30430492-92C345C0-B7FE-454C-8D9B-3A170B77DC32Q30431277-176671A3-1E21-4490-A4A0-26A7376B95ABQ44678507-E72CFE84-E0F5-4115-BBC5-D0C9AB5E25FAQ50083397-9C949F64-D988-40C8-8394-61473FA5FAA0Q51026525-F255757A-681F-4649-8AFA-7DEF109CA914Q52960400-5817E6F8-5D38-474D-81BE-D4D7951EA332Q53019150-77EC1BB7-F6F6-4B08-9184-1C9A886194AEQ54118155-74C0EC65-5B58-4D5B-8641-4A94097606CAQ58699236-CA903D5E-6D5E-4C55-87D9-385C00D54125
P2860
Does reperfusion injury still cause significant mortality after lung transplantation?
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Does reperfusion injury still cause significant mortality after lung transplantation?
@ast
Does reperfusion injury still cause significant mortality after lung transplantation?
@en
type
label
Does reperfusion injury still cause significant mortality after lung transplantation?
@ast
Does reperfusion injury still cause significant mortality after lung transplantation?
@en
prefLabel
Does reperfusion injury still cause significant mortality after lung transplantation?
@ast
Does reperfusion injury still cause significant mortality after lung transplantation?
@en
P2093
P1476
Does reperfusion injury still cause significant mortality after lung transplantation?
@en
P2093
Benjamin D Kozower
Brian R Swenson
Christine L Lau
Courtney J Kuhn
David R Jones
Lynn M Fedoruk
Philip W Smith
Sara A Hennessy
P304
P356
10.1016/J.JTCVS.2008.11.007
P407
P577
2009-03-01T00:00:00Z